News - TBVI

In Uncategorized Posted January 23, 2020

Workshop “Maintaining European scientific excellence and global leadership in EU funded collaborative TB Vaccine research and innovation” – Impact of three H2020 projects, TBVAC2020, EMI-TB and STriTuVaD, on the global TB vaccine pipeline (8 October 2019, Brussels)

Thanks to H2020 investments substantial progress has been made in the innovation and development of vaccines against TB. This is shown by the promising results of three H2020-funded TB vaccine [...]

By Marit Holleman

In Uncategorized Posted November 15, 2019

Publication: “Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations”

The publication preferred product characteristics (PPC) for therapeutic TB vaccines provides guidance to scientists, funding agencies, public and private sector organizations developing such [...]

By Marit Holleman

In Uncategorized Posted November 8, 2019

Vacancy at IGTP: Postdoctoral research fellow position available for a H2020-funded project

IGTP (Germans Trias o Pujol Research Institute) has a vacancy. Please read the vacancy text

By Cora Agterdenbosch

In Uncategorized Posted October 16, 2019

Les Diablerets 2020

TBVI is pleased to announce the TBVI meeting “Accelerating the TB vaccine pipeline – towards Horizon Europe” in Les Diablerets. The meeting will be held from 27th to 29th of January [...]

By Marit Holleman

In Uncategorized Posted October 15, 2019

TBVI and IAVI announce important updates to the TB Vaccine Development Pathway

The Tuberculosis Vaccine Initiative (TBVI) and IAVI have recently updated and expanded the TB Vaccine Development Pathway, a methodology and tool that provides a structured development path and [...]